Development, implementation, and feasibility of site-specific hepatitis C virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study — a prospective single-arm intervention trial

Peer Review reports

Original Submission
21 Dec 2022	Submitted	Original manuscript
13 Feb 2023	Reviewed	Reviewer Report - Stephen Bremner
31 Mar 2023	Reviewed	Reviewer Report - Gila Neta
14 Apr 2023	Author responded	Author comments - Anmol Desai
Resubmission - Version 2
14 Apr 2023	Submitted	Manuscript version 2
25 Apr 2023	Author responded	Author comments - Anmol Desai
Resubmission - Version 3
25 Apr 2023	Submitted	Manuscript version 3
Publishing
26 Apr 2023	Editorially accepted
8 May 2023	Article published	10.1186/s40814-023-01311-4

Back to article page